An early-stage AI company had already learned what it costs to bet on the wrong compliance platform. With a chaotic incumbent creating real operational risk, they needed to move fast, cover SOC 2 and HIPAA, and land somewhere they would not have to leave again. The evaluation was serious: five to six vendors compared, a hard price ceiling, and a decision deadline tied to receiving a credible migration plan. Drata won by combining compliance fit with a trust advantage the team could not find elsewhere, then closing the commercial gap that stood between intent and signature.
[ The Problem ]
Their compliance platform was failing them, and another bad choice would cost more than money.
The company had built its compliance program on a platform that had become unworkable. Getting off it was not optional. But the urgency of leaving created its own risk: a rushed replacement decision could mean a third migration in the near future.
At the same time, SOC 2 and HIPAA coverage were non-negotiable for the company's operations and customer expectations. Delaying compliance execution while sorting out tooling was not a viable path. The team needed a platform that could absorb the migration, deliver on both frameworks, and serve as a durable operating base rather than another short-lived stopgap.
[ What they needed ]
The team was simultaneously managing an urgent platform exit and a live compliance program build.
- Exit a failing compliance platform without disrupting compliance execution
- Stand up SOC 2 Type 1 and Type 2 alongside HIPAA coverage
- Evaluate five to six vendors under a compressed decision timeline
- Secure migration support to make the transition operationally manageable
- Find a platform credible enough to treat as a long-term GRC foundation
- Fit compliance tooling within a tight, bootstrapped budget on a one-year term
[ Why Drata won ]
Selected over Vanta, Drata's trusted reputation as a stable GRC platform gave a team burned by one failed incumbent the confidence to commit rather than hedge.
Trust as a displacement differentiator: the buyer was not evaluating from a neutral starting point. They had already experienced what a weak compliance platform costs. Drata's perceived stability and credibility in the GRC market made it the candidate the team viewed as a genuine long-term home base, not just the next option in the rotation.
Migration assurance closed the implementation gap: the buyer explicitly needed to know that moving off the prior platform was manageable before they would commit. Providing migration notes and sandbox access before signature treated implementation confidence as part of the close, not a post-sale promise.
Commercial flexibility met a hard ceiling: the buyer was bootstrapped, on a one-year term, and explicit about a price threshold. Drata moved into that range rather than holding on structure, which neutralized the bundled pricing advantage competitors had built and made the trust advantage actionable.
[ How Drata solved it ]
Drata GRC gave the team a structured path to SOC 2 and HIPAA coverage without requiring them to rebuild from scratch. The platform's support for both frameworks meant the compliance program could continue moving forward through the migration rather than pausing for it.
Drata's Trust Center addressed the customer-facing side of the compliance story, giving the team a way to share security posture with customers and prospects without fielding manual questionnaire requests. AIQA and TPRM extended that foundation into AI and third-party risk, covering the compliance surface area an AI company specifically needs to manage.
Critically, Drata provided migration notes and sandbox access before the deal closed. That was not a post-sale courtesy. It was the evidence the team needed to believe that moving off the prior platform was operationally manageable, not just theoretically possible. Combined with Drata's reputation as a stable, trusted GRC platform, that implementation confidence was what separated Drata from the field.
[ Before and after Drata ]
Before Drata, the team was operating on a platform they needed to exit immediately, with no clear migration path and compliance execution at risk of slipping through the transition.
After, SOC 2 and HIPAA work is moving forward on a single stable platform, the migration from the prior tool was scoped before day one, and the team has closed the vendor evaluation cycle they had been running across five to six options.
[ Business outcome ]
The company closed on a platform they intend to stay on. That outcome matters more than it might appear for a team that had already absorbed the cost of one failed compliance tooling decision.
SOC 2 and HIPAA execution can now move forward on a single platform without the operational drag of a chaotic incumbent or the looming cost of another vendor evaluation. The migration path from the prior platform was defined before the contract was signed, reducing the risk that onboarding would surface surprises the team was not prepared for.
For a bootstrapped company at this stage, eliminating the compliance tooling question frees the team to focus on the program itself rather than the infrastructure underneath it.